부산대학교 도서관

Harter P; Department for Gynecology and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; Philipps-University of Marburg, Marburg, Germany.; AGO Study Group, Wiesbaden, Germany.; Marmé F; AGO Study Group, Wiesbaden, Germany.; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Redondo A; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; GEICO, Madrid, Spain.; Reuss A; AGO Study Group, Wiesbaden, Germany.; Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany.; Lindemann K; Section for Gynaecologic Oncology, Department of Surgical Oncology, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.; NSGO-CTU, Copenhagen, Denmark.; Kurzeder C; Department for Gynecology and Gynecologic Oncology, University Hospital Basel, Basel, Switzerland.; SAKK, Bern, Switzerland.; Van Nieuwenhuysen E; UZ Leuven, University Hospitals Leuven, Leuven, Belgium.; BGOG, Leuven, Belgium.; Marth C; Department of Gynecology and Obstetrics, Medizinische Universität Innsbruck, Innsbruck, Austria.; AGO-Austria, Innsbruck, Austria.; Pietzner K; AGO Study Group, Wiesbaden, Germany.; Department of Gynecology, Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Ray-Coquard I; Centre Léon Bérard, University Claude Bernard Lyon, Lyon, France.; GINECO, Paris, France.; Garcia-Duran C; GEICO, Madrid, Spain.; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; Jonuskiene G; NSGO-CTU, Copenhagen, Denmark.; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.; Heitz F; Department for Gynecology and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; AGO Study Group, Wiesbaden, Germany.; Department of Gynecology, Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Béllier C; GINECO, Paris, France.; Centre Oscar Lambret, Lille, France.; Pérez-Fidalgo JA; GEICO, Madrid, Spain.; Medical Oncology Department, University Hospital of Valencia, INCLIVA Biomedical Research Institute, CIBERONC, Valencia, Spain.; El-Balat A; AGO Study Group, Wiesbaden, Germany.; Universitätsspital Zürich, Zurich, Switzerland.; Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Klinik für Frauenheilkunde und Geburtshilfe, Frankfurt, Germany.; Selle F; GINECO, Paris, France.; Groupe Hospitalier Diaconesses, Croix Saint-Simon, Paris, France.; Romero I; GEICO, Madrid, Spain.; Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.; Wimberger P; AGO Study Group, Wiesbaden, Germany.; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, TU Dresden and NCT Dresden, Dresden, Germany.; Follana P; GINECO, Paris, France.; Centre Antoine Lacassagne, Nice, France.; Pardo B; GEICO, Madrid, Spain.; Institut Català d'Oncologia (ICO) Duran i Reynals, Barcelona, Spain.; de Gregorio N; AGO Study Group, Wiesbaden, Germany.; Universitätsklinikum Ulm, Klinik für Frauenheilkunde und Geburtshilfe, Ulm, Germany.; SLK-Kliniken Heilbronn GmbH, Frauenklinik, Heilbronn, Germany.; Joly F; GINECO, Paris, France.; Centre François Baclesse, Caen, France.; Gaba L; GEICO, Madrid, Spain.; Medical Oncology Department, Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Burges A; AGO Study Group, Wiesbaden, Germany.; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.; Fabbro M; GINECO, Paris, France.; ICM Val d'Aurelle, Montpellier, France.; Hasenburg A; AGO Study Group, Wiesbaden, Germany.; Department of Gynecology and Obstetrics, University Medical Center Mainz, Mainz, Germany.; Fehm T; AGO Study Group, Wiesbaden, Germany.; Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.; Schmalfeldt B; AGO Study Group, Wiesbaden, Germany.; Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Pautier P; GINECO, Paris, France.; Gustave Roussy, Villejuif, France.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

de la Haba-Rodríguez JR; Medical Oncology Department, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universi-tario Reina Sofía, Universidad de Córdoba, Av. Menendez Pidal, S/N, Córdoba, 14004, Spain. juahaba@gmail.com.; GEICAM Spanish Breast Cancer Group, Madrid, Spain. juahaba@gmail.com.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain. juahaba@gmail.com.; Mínguez P; Bioinformatics Unit, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM) Madrid, Madrid, Spain.; Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM) Madrid, Madrid, Spain.; Center for Biomedical Network Research On Rare Diseases (CIBERER), ISCIII, Madrid, Spain.; Rojo F; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Pathology Service, Hospital Universitario Fundación Jiménez Díaz Madrid, Madrid, Spain.; Martín M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Medical Oncology, Medicine Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.; Alba E; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Medical Oncology, Hospitales Universitarios Regional y Virgen de La Victoria Málaga, Malaga, Spain.; Clinical and Translational Research, Instituto de Investigación Biomédica de Málaga (IBIMA) Málaga, Malaga, Spain.; Servitja S; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Medical Oncology, Hospital del Mar, Barcelona, Spain.; Prat A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology, Hospital Clinic Barcelona, Barcelona, Spain.; Pérez-Fidalgo JA; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Medicine Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), Universidad de Valencia, Valencia, Spain.; Gavilá J; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain.; Morales C; Medical Oncology Department, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universi-tario Reina Sofía, Universidad de Córdoba, Av. Menendez Pidal, S/N, Córdoba, 14004, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Rodriguez-Lescure A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain.; Herrero C; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Consorcio Hospitalario Provincial de Castellón, Castellón, Spain.; Peña-Enriquez R; Medical Oncology Department, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universi-tario Reina Sofía, Universidad de Córdoba, Av. Menendez Pidal, S/N, Córdoba, 14004, Spain.; Herranz J; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hernando C; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medicine Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), Universidad de Valencia, Valencia, Spain.; Hernández-Blanquisett A; Instituto de Cáncer, Centro Hospitalario Serena del Mar, Cartagena, Colombia.; Guil-Luna S; Medical Oncology Department, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universi-tario Reina Sofía, Universidad de Córdoba, Av. Menendez Pidal, S/N, Córdoba, 14004, Spain.; Martinez MT; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medicine Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), Universidad de Valencia, Valencia, Spain.; Blanch S; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain.; Caballero R; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Martín N; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Pollán M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Guerrero-Zotano A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain.; Bermejo B; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Medicine Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), Universidad de Valencia, Valencia, Spain.

Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 9601804 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7039 (Electronic) Linking ISSN: 10833021 NLM ISO Abbreviation: J Mammary Gland Biol Neoplasia Subsets: MEDLINE

Perez-Fidalgo JA; Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. japfidalgo@msn.com.; Gálvez-Montosa F; Hospital Universitario de Jaén, Jaén, Spain.; Guerra EM; Hospital Universitario Ramon y Cajal, Madrid, Spain.; Madariaga A; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Manzano A; Hospital Clínico San Carlos, Madrid, Spain.; Martin-Lorente C; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Rubio-Pérez MJ; Hospital Universitario Reina Sofía, Universidad de Córdoba (UCO), Córdoba, Spain.; Alarcón J; Hospital Universitari Son Espases, Mallorca, Spain.; Barretina-Ginesta MP; Institut Català d'Oncologia, Medical Oncology Department, Precision Oncology Group, Institut d'Investigació Biomèdica de Girona (IDIBGI), Medical Sciences Department, Universitat de Girona, Girona, Spain.; Gaba L; Medical Oncology Department, Hospital Clinic, Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Department of Medicine, University of Barcelona, Barcelona, Spain.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Alvarez CS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.; Piazuelo MB; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Fleitas-Kanonnikoff T; Department of Medical Oncology, Instituto de Investigación Sanitaria (INCLIVA) Biomedical Research Institute, University of Valencia, Valencia, Spain.; Ruhl J; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.; Pérez-Fidalgo JA; Medical Oncology Department, University Hospital of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.; Centro de Investigación Biomédica en Red Cáncer, Valencia, Spain.; Camargo MC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Villacampa G; Eminowicz G; Navarro V; Carità L; García-Illescas D; Oaknin A; Pérez-Fidalgo JA

EUROPEAN JOURNAL OF CANCER
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Montero P; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.; Sanz C; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Biomedical Research Networking Centre on Cancer (CIBERONC), Health Institute Carlos III, Madrid, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain.; Pérez-Leal M; Faculty of Health Sciences, Universidad Europea de Valencia, Valencia, Spain.; Milara J; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, Madrid, Spain.; Pharmacy Unit, University General Hospital Consortium, Valencia, Spain.; Cortijo J; Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, Madrid, Spain.; Research and Teaching Unit, University General Hospital Consortium, Valencia, Spain.

Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-8206 (Electronic) Linking ISSN: 07673981 NLM ISO Abbreviation: Fundam Clin Pharmacol Subsets: MEDLINE

Pérez-Fidalgo JA; Oncology and Hematology Department, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario, CIBERONC Spain, Avda Blasco Ibañez 17, Valencia, 46010, Spain.; Ortega E; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Ponce J; Gynecology Department, Hospital Universitario de Bellvitge. IDIBELL. Universidad de Barcelona, Barcelona, Spain.; Redondo A; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Sevilla I; Clinical and Translational Research in Cancer/Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional and Virgen de la Victoria de Málaga, Málaga, Spain.; Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Isern Verdum J; Radiotherapy Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; de Alava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital /CSIC/University of Sevilla/CIBERONC, Sevilla, Spain.; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain.; Galera López M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Marquina G; Department of Medical Oncology, Hospital Clinico San Carlos, Madrid, IdISSC, Spain.; Department of Medicine, School of Medicine, Complutense University (UCM), Madrid, IdISSC, Spain.; Sebio A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona.; Universitat Autònoma de Barcelona, Barcelona, Spain.; Institut de Recerca Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.

Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

González-Martín A; Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Rubio MJ; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Reina Sofia University Hospital of Cordoba, Cordoba, Spain.; Heitz F; Department for Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynaecology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO), Wiesbaden, Germany.; Depont Christensen R; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Mario Negri Gynecologic Oncology Group (MaNGO), Milan, Italy.; Van Gorp T; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Romeo M; Medical Oncology Department, Institut Català d'Oncologia, Institut Germans Trias i Pujol (IGTP), Badalona, Spain.; Centre Leon Bérard and University of Lyon, Lyon, France.; Ray-Coquard I; Centre Leon Bérard and University of Lyon, Lyon, France.; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Gaba L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Leary A; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Gustave Roussy, Villejuif, France.; De Sande LM; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Service, Complejo Asistencial Universitario de León, León, Spain.; Lebreton C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Medical Oncology Department-Gynecologic Group, Institut Bergonié-Centre Régional de Lutte Contre le Cancer (CLCC), Bordeaux, France.; Redondo A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Fabbro M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France.; Barretina Ginesta MP; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Institut Català d'Oncologia, IDIBGI, Girona, Spain.; Follana P; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Centre Antoine Lacassagne, Nice, France.; Pérez-Fidalgo JA; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, University Hospital of Valencia, INCLIVA Biomedical Research Institute, CIBERONC, Valencia, Spain.; Rodrigues M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut Curie, Paris, France.; Santaballa A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain.; Sabatier R; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut Paoli Calmettes, Marseille, France.; Bermejo-Pérez MJ; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.; Lotz JP; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Hôpital Tenon, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.; Pardo B; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Marquina G; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Department of Medical Oncology, Department of Medicine, Hospital Clínico San Carlos, School of Medicine, Instituto de Investigación Sanitaria (IdISSC), EURACAN Referral Centre, Universidad Complotense de Madrid (UCM), Madrid, Spain.; Sánchez-Lorenzo L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Clínica Universidad de Navarra, Madrid, Spain.; Quindós M; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, A Coruña, Spain.; Estévez-García P; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Virgen del Rocío and Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.; Guerra Alía E; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Ramón y Cajal, Madrid, Spain.; Manso L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain.; Casado V; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain.; Kommoss S; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO), Wiesbaden, Germany.; Universitätsklinikum Tübingen, Universitätsfrauenklinik, Tübingen, Germany.; Current address: Diakonie-Klinikum Schwäbisch Hall gGmbH, Schwäbisch Hall, Germany.; Tognon G; Mario Negri Gynecologic Oncology Group (MaNGO), Milan, Italy.; Spedali Civili di Brescia, Brescia, Italy.; Henry S; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; CHU UCL NAMUR (site Ste Elisabeth), Université Catholique de Louvain, Namur, Belgium.; Bruchim I; Gynecologic Oncology Department, Hillel Yaffe Medical Center, Affiliated with the Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Israeli Society of Gynecologic Oncology (ISGO), Ashkelon, Israel.; Oaknin A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Selle F; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Medical Oncology Service, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Carrillo-García J; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain; Medical Oncology Department, University Hospital General de Villalba, Madrid, Spain. Electronic address: jcarrillo@atbsarc.org.; Hindi N; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain; Medical Oncology Department, University Hospital General de Villalba, Madrid, Spain; Medical Oncology Department, University Hospital Fundación Jiménez Díaz, Madrid, Spain. Electronic address: nhindi@atbsarc.org.; Conceicao M; University Hospital Son Espases, Palma, Spain. Electronic address: magdacristina.daconceicao@ssib.es.; Sala MÁ; Medical Oncology Department, Basurto University Hospital, Bilbao, Spain. Electronic address: MARIAANGELES.SALAGONZALEZ@osakidetza.eus.; Ugalde A; Pathology Department, Basurto University Hospital, Bilbao, Spain. Electronic address: AITZIBER.UGALDEOLANO@osakidetza.eus.; López-Pousa A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: ALopezP@santpau.cat.; Bagué S; Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: sbaguer@santpau.cat.; Sevilla I; Clinical and Translational Research in Cancer/Biomedical Reseach Institute of Malaga (IBIMA), University Hospitals Regional and Virgen de la Victoria, Malaga, Spain. Electronic address: isevilla02@yahoo.es.; Vicioso L; Pathology Department, University Hospital Virgen de la Victoria, IBIMA-Plataforma Bionand, Malaga, Spain. Electronic address: vicioso@uma.es.; Ramos R; Pathology Department, University Hospital Son Espases, Palma, Spain. Electronic address: rafaelf.ramos@quironsalud.es.; Martínez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain. Electronic address: jmtrufero@seom.org.; Gómez Mateo MC; Pathology Department, University Hospital Miguel Servet, Zaragoza, Spain. Electronic address: mcgomezmateo@hotmail.com.; Cruz J; Medical Oncology Department, University Hospital of Canarias, Santa Cruz de Tenerife, Spain. Electronic address: jcruzjurado@gmail.com.; Hernández-León CN; Pathology Department, University Hospital of Canarias, Santa Cruz de Tenerife, Spain. Electronic address: nievleon34@gmail.com.; Redondo A; Medical Oncology Department, University Hospital La Paz-IdiPAZ, Madrid, Spain. Electronic address: andres.redondos@uam.es.; Mendiola M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Hospital La Paz Institute for Health Research - IDIPAZ, La Paz University Hospital, Madrid, Spain. Electronic address: marta.mendiola@salud.madrid.org.; García JM; Oncology Department, University Hospital Virgen de la Arrixaca, Murcia, Spain. Electronic address: jeronimo@seom.org.; Hernández JE; Pathology Department, University Hospital Virgen de la Arrixaca, Murcia, Spain. Electronic address: joseemilio99@yahoo.es.; Álvarez R; Medical Oncology Department, University Hospital Gregorio Marañón, Madrid, Spain. Electronic address: rosa.alvarez.al@gmail.com.; Agra C; Pathology Department, University Hospital Gregorio Marañón, Madrid, Spain. Electronic address: caroagra@gmail.com.; de Juan-Ferré A; Medical Oncology Department, University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain. Electronic address: anade.juan@scsalud.es.; Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: cvalverde@vhio.net.; Cano JM; Medical Oncology Department, University Hospital of Ciudad Real, Ciudad Real, Spain. Electronic address: juanamariacano@gmail.com.; Sande LM; Medical Oncology Department, University Hospital of León, León, Spain. Electronic address: lmgdesande@gmail.com.; Pérez-Fidalgo JA; Hematology and Medical Oncology Department, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. Electronic address: apfidalgo@msn.com.; Lavernia J; Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. Electronic address: javilavernia@gmail.com.; Marcilla D; Pathology Department, University Hospital Virgen del Rocío, Sevilla, Spain. Electronic address: david.marcilla.sspa@juntadeandalucia.es.; Gutiérrez A; Department of Haematology, University Hospital Son Espases, IdISBa, Palma, Spain. Electronic address: antoniom.gutierrez@ssib.es.; Moura DS; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain; Medical Oncology Department, University Hospital General de Villalba, Madrid, Spain. Electronic address: dmoura@atbsarc.org.; Martín-Broto J; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain; Medical Oncology Department, University Hospital General de Villalba, Madrid, Spain; Medical Oncology Department, University Hospital Fundación Jiménez Díaz, Madrid, Spain. Electronic address: jmartin@atbsarc.org.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Pernas S; Martin M; Kaufman PA; Gil-Martin M; Gomez Pardo P; Lopez-Tarruella S; Manso L; Ciruelos E; Perez-Fidalgo JA; Hernando C; Ademuyiwa FO; Weilbaecher K; Mayer I; Pluard TJ; Martinez Garcia M; Vahdat L; Perez-Garcia J; Wach A; Barker D; Fung S; Romagnoli B; Cortes J

LANCET ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
The Lancet. Oncology

Makker V; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical Center, New York, NY, USA.; Perez-Fidalgo JA; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Valabrega G; University of Turin, A.O. Ordine Mauriziano, Turin, Italy.; Hamilton E; Sarah Cannon Research Institute, Nashville, TN, USA.; Van Gorp T; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Sehouli J; European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, NOGGO, Charité-Berlin University of Medicine, Berlin, Germany.; Regináčová K; Department of Oncology, University Hospital Kralovske Vinohrady, Prague, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic.; Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Perri T; Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.; Oza AM; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.; Miller DS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Alía EMG; Hospital Universitario Ramón y Cajal, Madrid, Spain.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.; Henry S; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and Université Catholique de Louvain CHU UCL Site Ste Elisabeth, Service d'onco-hématologie (SORMIN), Namur, Belgium.; Spitz DL; Sarah Cannon Research Institute, Nashville, TN, USA; Florida Cancer Specialists & Research Institute, Wellington, FL, USA.; Wimberger P; University Hospital Carl Gustav Carus, NOGGO, and Technische Universität Dresden, Dresden, Germany.; Bednaříková M; University Hospital and Masaryk University, Brno, Prague, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic.; Chon HS; Moffitt Cancer Center, Tampa, FL, USA.; Martínez-Garcia J; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-ARRIXACA, Murcia, Spain.; Pisano C; Istituto Nazionale Tumori di Napoli, Naples, Italy.; Berek JS; Stanford Women's Cancer Center, Stanford Cancer Institute, University School of Medicine, Stanford, CA, USA.; Romero I; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Scambia G; Università Cattolica del Sacro Cuore, Rome 00168, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome 00168, Italy.; Fariñas-Madrid L; Vall d'Hebron Universitiy Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Buscema J; Arizona Oncology, Tucson, AZ, USA.; Schochter F; University Hospital Ulm, Ulm, Germany.; Li K; Karyopharm Therapeutics Inc., Newton, MA, USA.; Kalyanapu P; Karyopharm Therapeutics Inc., Newton, MA, USA.; Walker CJ; Karyopharm Therapeutics Inc., Newton, MA, USA.; Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: Ignace.vergote@uzleuven.be.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Redondo A; Hospital Universitario La Paz-IdiPAZ, Universidad Autónoma de Madrid (UAM), Paseo de la Castellana 261, 28046, Madrid, Spain. andres.redondos@uam.es.; Guerra E; Hospital Universitario Ramón y Cajal, Madrid, Spain.; Manso L; Hospital Universitario 12 de Octubre-i+12, Madrid, Spain.; Martin-Lorente C; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Martinez-Garcia J; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Perez-Fidalgo JA; Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.; Varela MQ; Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.; Rubio MJ; Hospital Universitario Reina Sofía, Universidad de Córdoba (UCO), Córdoba, Spain.; Barretina-Ginesta MP; Girona Biomedical Research Institute (IdIBGi) and Department of Medical Sciences, Instituto Catalán de Oncología (ICO), Medical School University of Girona, Girona, Spain.; Gonzalez-Martin A; Clínica Universidad de Navarra, Madrid, Spain.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Ledermann JA; Department of Oncology, UCL Cancer Institute, University College London, London, UK. Electronic address: clinicalguidelines@esmo.org.; Matias-Guiu X; CIBERONC, Madrid; Department of Pathology, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, University of Lleida, Lleida; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain. Electronic address: admin@esp-pathology.org.; Amant F; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Concin N; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria; Department of Gynaecology and Gynaecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; Davidson B; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Fotopoulou C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; González-Martin A; Department of Medical Oncology and Program in Solid Tumours-Cima, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Gourley C; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Leary A; Department of Medicine, Institut Gustave Roussy, Villejuif, France.; Lorusso D; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy.; Banerjee S; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.; Chiva L; Department of Gynaecology and Obstetrics, Cancer Center Clínica Universidad de Navarra, Navarra, Spain.; Cibula D; Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Colombo N; Department of Gynecologic Oncology, Istituto Europeo di Oncologia IRCCS, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.; Croce S; Department of Biopathology, Bergonié Institut, Bordeaux, France.; Eriksson AG; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Falandry C; Institute of Aging, Hospices Civils de Lyon, Lyon; CarMeN Laboratory, INSERM U1060/Université Lyon 1/INRAE U1397/Hospices Civils Lyon, Pierre-Bénite, France.; Fischerova D; Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Harter P; Department of Gynaecology and Gynaecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany.; Joly F; GINECO Group, Department of Medical Oncology, Centre François-Baclesse, University of Caen Normandy, Caen, France.; Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain.; Lok C; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich.; Marmé F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany; Department of Obstetrics and Gynecology, University Hospital Mannheim, Mannheim; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Marth C; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.; McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.; McNeish IA; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Morice P; Department of Gynecologic Surgery, Gustave Roussy Cancer Campus, Villejuif, France.; Nicum S; Department of Oncology, UCL Cancer Institute, University College London, London, UK.; Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario - INCLIVA, CIBERONC, Valencia, Spain.; Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS Fondazione Pascale, Napoli, Italy.; Ramirez PT; Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, USA.; Ray-Coquard I; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard, Lyon, France.; Romero I; Department of Medical Oncology, Instituto Valenciano Oncologia, Valencia, Spain.; Scambia G; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy.; Sehouli J; North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin; Department of Gynecology with Center for Oncological Surgery, Charité Berlin University of Medicine, Berlin, Germany.; Shapira-Frommer R; Sheba Medical Center, Ramat Gan, Israel.; Sundar S; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham; Pan Birmingham Gynaecological Cancer Centre, City Hospital, Birmingham, UK.; Tan DSP; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; National University of Singapore (NUS) Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer Science Institute, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore, Singapore.; Taskiran C; Department of Gynecologic Oncology, School of Medicine, Koç University, Istanbul, Turkey.; van Driel WJ; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Vergote I; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Planchamp F; Institut Bergonié, Bordeaux, France.; Sessa C; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.; Fagotti A; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy. Electronic address: guidelines@esgo.org.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Eden D; Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, U.K.; Ghose A; Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, U.K.; Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, U.K.; Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London, U.K.; Immuno-Oncology Clinical Network, Liverpool, U.K.; Moschetta M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Pérez-Fidalgo JA; Hematology and Medical Oncology Department, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.; Rassy E; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France.; Boussios S; Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, U.K.; stergiosboussios@gmail.com stergios.boussios@nhs.net stergios.boussios@kcl.ac.uk s.boussios@kent.ac.uk stergios.boussios@kmms.ac.uk.; Faculty of Medicine, Health, and Social Care, Canterbury Christ Church University, Canterbury, U.K.; Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London, U.K.; Kent Medway Medical School, University of Kent, Canterbury, U.K.; AELIA Organization, Thessaloniki, Greece.

Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

Jhaveri KL; Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York, and Weill Cornell Medical College, New York, New York.; Bellet M; Oncology Department, Breast Cancer Unit, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, and The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Bardia A; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Boni V; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, HM Hospitales Sanchinarro, Madrid, Spain.; Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.; Neilan TG; Division of Cardiology, Department of Medicine, Cardio-Oncology Program, Massachusetts General Hospital, Boston, Massachusetts.; Villanueva-Vázquez R; Institut Català d'Oncologia, l'Hospitalet-Hospital Duran i Reynals, Barcelona, Spain.; Kabos P; School of Medicine, University of Colorado, Aurora, Colorado.; García-Estévez L; Breast Cancer Department, MD Anderson Cancer Center Madrid, Madrid, Spain.; López-Miranda E; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Pérez-Fidalgo JA; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain.; Pérez-García JM; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey.; Yu J; Clinical Pharmacology, Genentech, Inc., South San Francisco, California.; Fredrickson J; Genentech Research and Early Development (gRED), Genentech, Inc., South San Francisco, California.; Moore HM; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.; Chang CW; PHC and Early Development Oncology Biostatistics, Genentech, Inc., South San Francisco, California.; Bond JW; Product Development Safety, Genentech, Inc., South San Francisco, California.; Eng-Wong J; Genentech Research and Early Development (gRED), Genentech, Inc., South San Francisco, California.; Gates MR; Genentech Research and Early Development (gRED), Genentech, Inc., South San Francisco, California.; Lim E; St. Vincent's Hospital and Garvan Institute of Medical Research, University of New South Wales, Sydney, New South Wales, Australia.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: aoaknin@vhio.net.; Gladieff L; Oncopole Claudius Regaud, IUCT, Toulouse, France.; Martínez-García J; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; The Institute of Cancer Research, London, UK.; Takekuma M; Shizuoka Cancer Center, Shizuoka, Japan.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.; Lindemann K; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway.; Woelber L; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Colombo N; Gynecologic Oncology Department, European Institute of Oncology IRCCS Milan, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Duska L; University of Virginia Cancer Center, Charlottesville, VA, USA.; Leary A; Gustave Roussy, Villejuif, France.; Godoy-Ortiz A; Hospital Regional de Málaga, Málaga, Spain.; Nishio S; Kurume University Hospital, Fukuoka, Japan.; Angelergues A; Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.; Rubio MJ; Hospital Universitario Reina Sofia, Córdoba, Spain.; Fariñas-Madrid L; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Yamaguchi S; Hyogo Cancer Center, Hyogo, Japan.; Lorusso D; Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Catholic University of Sacred Heart, Rome, Italy.; Ray-Coquard I; Centre Léon Bérard, Lyon, France.; Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Joly F; Centre François Baclesse, Caen, France.; Alarcón J; Hospital Universitari Son Espases, Mallorca, Spain.; Follana P; Centre Antoine Lacassagne, Nice, France.; Romero I; Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.; Lebreton C; Institut Bergonié, Bordeaux, France.; Pérez-Fidalgo JA; University Hospital of Valencia, Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain; CIBERONC, Valencia, Spain.; Yunokawa M; Cancer Institute Hospital of JFCR, Tokyo, Japan.; Dahlstrand H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.; D'Hondt V; Institut du Cancer de Montpellier, Montpellier, France.; Randall LM; Massey Comprehensive Cancer Center, VCUHealth, Richmond, VA, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Saura C; Roda D; Roselló S; Oliveira M; Macarulla T; Pérez-Fidalgo JA; Morales-Barrera R; Sanchis-García JM; Musib L; Budha N; Zhu J; Nannini M; Chan WY; Sanabria Bohórquez SM; Meng RD; Lin K; Yan Y; Patel P; Baselga J; Tabernero J; Cervantes A

Cancer Discovery
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. matteo.lambertini@unige.it.; Department of Medical Oncology, U.O.C, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. matteo.lambertini@unige.it.; Ceppi M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Hamy AS; Department of Medical Oncology, Institut Curie, Paris, France.; Caron O; Department of Medical Oncology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Poorvu PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Carrasco E; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Grinshpun A; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; Punie K; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Rousset-Jablonski C; Department of Surgery, Centre Léon Bérard, Lyon, France.; Ferrari A; Department of Surgical Sciences, General Surgery III - Breast Surgery, Fondazione IRCCS Policlinico San Matteo, University of Pavia, aBRCAdaBRA onlus, Pavia, Italy.; Paluch-Shimon S; Breast Oncology Unit, Shaare Zedek Medical Centre and Department of Oncology, Sheba Medical Center, Tel Hashomer, Jerusalem, Israel.; Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.; Senechal C; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France.; Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy.; Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Pérez-Fidalgo JA; Department of Medical Oncology, INCLIVA University Hospital of Valencia, CIBERONC, Valencia, Spain.; De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, 'La Sapienza' University of Rome, Rome, Italy.; Ponzone R; Gynecological Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Turin, Italy.; Livraghi L; Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.; University of Siena, Siena, Italy.; Estevez-Diz MDP; Departament of Oncology, Instituto do Cancer do Estado de Sao Paulo - Faculdade de Medicina da Universidade de Sao Paulo, Pacaembu, Sao Paulo, Brazil.; Villarreal-Garza C; Department of Research and Breast Tumors, Mexican National Cancer Institute, Mexico City, Mexico.; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, NL, Mexico.; Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.; Duhoux FP; Department of Medical Oncology, Breast Clinic, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.; Graffeo R; Breast Unit of Southern Switzerland (CSSI), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Teixeira L; Breast Disease Unit, Saint-Louis Hospital, APHP, Université de Paris, INSERM U976, Paris, France.; Córdoba O; Obstetrics and Gynecology Department, Hospital Universitari Son Espases, Palma, Spain.; Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel.; Ferreira AR; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Di Meglio A; Predictive Biomarkers and New Therapeutic Strategies in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Saule C; Department of Genetics, Institut Curie, Paris, France.; Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.; Bruzzone M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; t'Kint de Roodenbeke MD; Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.; Ameye L; Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.; Balmaña J; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, NL, Mexico.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Vergote I; BGOG, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Pérez-Fidalgo JA; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Spain.; Hamilton EP; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Valabrega G; MITO and Department of Oncology, University of Torino, Mauriziano Hospital, Turin, Italy.; Van Gorp T; BGOG, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Sehouli J; Department of Gynecology, NOGGO, European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, Charité-Berlin University of Medicine, Berlin, Germany.; Cibula D; CEEGOG, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Levy T; Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, ISGO, Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Holon, Israel.; Welch S; London Health Sciences Centre, London, ON, Canada.; Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.; Guerra EM; GEICO, Hospital Universitario Ramon y Cajal, Madrid, Spain.; Scambia G; MITO, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Henry S; CHU UCL Namur Site Ste Elisabeth, Service d'onco-hématologie (SORMN), BGOG and Université Catholique de Louvain, Namur, Belgium.; Wimberger P; Department of Obstetrics and Gynecology, University Hospital Carl Gustav Carus, NOGGO and Technische Universitat Dresden, Dresden, Germany.; Miller DS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.; Klat J; University Hospital Ostrava and University of Ostrava, Ostrava-Poruba, Czech Republic.; Martínez-Garcia J; Department of Oncology, GEICO, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.; Raspagliesi F; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy.; Pothuri B; NYU Langone Health, Perlmutter Cancer Center, New York University School of Medicine, New York, NY.; Romero I; Medical Oncology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.; Bergamini A; Department of Obstetrics and Gynecology, San Raffaele Milano, Milano, Italy.; Università Vita-Salute San Raffaele, Milano, Italy.; Slomovitz B; Mount Sinai Medical Center, Florida International University, Miami, FL.; Schochter F; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Høgdall E; Department of Pathology, Herlev Hospital Copenhagen University Hospital, Copenhagen, Denmark.; Fariñas-Madrid L; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Monk BJ; GOG, HonorHealth, University of Arizona, Creighton University, Phoenix, AZ.; Michel D; Karyopharm Therapeutics, Newton, MA.; Kauffman MG; Karyopharm Therapeutics, Newton, MA.; Shacham S; Karyopharm Therapeutics, Newton, MA.; Mirza MR; Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.; Makker V; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Ibarrola-Villava M; Llorca-Cardeñosa MJ; Tarazona N; Mongort C; Fleitas T; Perez-Fidalgo JA; Roselló S; Navarro S; Ribas G; Cervantes A

Oncotarget
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname